<DOC>
	<DOCNO>NCT00883766</DOCNO>
	<brief_summary>The aim study compare two different IVF-stimulation protocol patient affect PCOS : use Gonadotropin-releasing hormone ( GnRH ) - antagonist start day 1 control ovarian hyperstimulation ( COH ) versus standard long agonist protocol ; order ass whether affect number quality Metaphase II ( MII ) oocytes reduce risk hyperstimulation . Since PCOS patient also likely insulin resistant also aim evaluate metformin affect tha IVF stimulation outcome .</brief_summary>
	<brief_title>Polycystic Ovary Syndrome ( PCOS ) In Vitro Fertilization ( IVF ) : A Comparison Between Standard Long Protocol Versus Antagonist Protocol Starting Day 1</brief_title>
	<detailed_description>Hejinen et al ( 1 ) recently conduct meta-analysis compare outcomes conventional IVF woman present polycystic ovary syndrome ( PCOS ) non-PCOS patient . They compare nine RCTs report data 458 PCOS patient ( 793 cycle ) 694 match control ( 1116 cycle ) conclude PCOS increase cancellation rate , oocytes retrieve per pick-up low fertilization rate . Overall , PCOS control patient achieve similar pregnancy live birth rate per cycle . The incidence ovarian hyperstimulation syndrome ( OHSS ) oocyte retrieval rarely report . Our result accordance meta-analysis . Therefore , pregnancy abortion rate PCOS control differ , main problem deal PCOS IVF OHSS . This condition approach use antagonist instead agonist , change kind ovulation trigger co-treating patient metformin . - One currently debatable issue regard use GnRH antagonists refers time GnRH antagonist initiation . A fixed protocol start antagonist arbitrarily Day 6 stimulation use introductory comparative trial employ daily antagonist administration ( 2 ) . Following trial , flexible antagonist initiation follicle 14-15 mm evaluate . Currently , initiation antagonist early follicular phase PCOS patient perform Lainas coll . ( 3 ) treat patient PCOS either long GnRH agonist scheme fix day-1 GnRH antagonist protocol conclude initiation GnRH antagonist concomitantly recombinant FSH day 1 associate early follicular growth different hormonal environment follicular phase compare long agonist protocol . This may lead reduction incidence OHSS . - Over past 15 year , become increasingly recognize insulin resistance central pathogenesis PCOS ( 4 ) . Metformin , biguanide insulin-lowering agent , extensively investigated management PCOS . Two recent systematic review ( 5 , 6 ) demonstrate metformin improves reproductive function woman PCOS . Metformin also appear improve outcome ovulation induction therapy combine clomiphene gonadotrophin . Tang et al . recently study PCOS overweight patient undergo IVF administer 850 mg bid placebo 28 day prior stimulation ( 7 ) . They conclude short-term co-treatment metformin patient PCOS undergo IVF/ICSI cycle improve response stimulation significantly improve pregnancy outcome reduces risk OHSS . The aim study verify use antagonist number quality MII oocytes equal compare standard long agonist protocol reduce risk hyperstimulation . Outcome measure : Primary endpoint : - Oocytes MII Secondary endpoint - Fertilization rate - Pregnancy rate - Miscarriage rate - Incidence OHSS</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Polycystic Ovary Syndrome</mesh_term>
	<criteria>PCOS patient accord Rotterdam consensus criterion Presence ovary Absence endometriomas detect ultrasound FSH &lt; 10 IU/L day 3 cycle E2 &lt; 80 pg/mL , Pg &lt; 1.6 ng/mL initiation stimulation Congenital adrenal hyperplasia Cushing 's syndrome Androgenproducing tumours Hyperprolactinaemia thyroid dysfunction Age &gt; 38 year Serum FSH level &gt; 10 mIU/ml</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>October 2010</verification_date>
	<keyword>Polycystic Ovary Syndrome</keyword>
	<keyword>GnRH Antagonist</keyword>
	<keyword>Long Agonist Protocol</keyword>
	<keyword>OHSS</keyword>
</DOC>